C Chatelain

3.6k total citations
170 papers, 2.6k citations indexed

About

C Chatelain is a scholar working on Surgery, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C Chatelain has authored 170 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 34 papers in Hematology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C Chatelain's work include Urological Disorders and Treatments (15 papers), Renal Transplantation Outcomes and Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). C Chatelain is often cited by papers focused on Urological Disorders and Treatments (15 papers), Renal Transplantation Outcomes and Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). C Chatelain collaborates with scholars based in France, Belgium and United States. C Chatelain's co-authors include François Mullier, Jean‐Michel Dogné, Bernard Châtelain, Jonathan Douxfils, R Küss, Carlos Graux, Séverine Robert, Bérangère Devalet, Hélène Haguet and Jean-Michel Dogné and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

C Chatelain

152 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Chatelain France 27 913 707 665 426 390 170 2.6k
Antonio Ordinas Spain 35 629 0.7× 419 0.6× 2.1k 3.2× 365 0.9× 552 1.4× 173 3.6k
Victor Gurewich United States 32 864 0.9× 862 1.2× 1.5k 2.3× 559 1.3× 596 1.5× 144 4.0k
J. Vermylen Belgium 31 486 0.5× 305 0.4× 1.1k 1.6× 211 0.5× 533 1.4× 110 2.6k
D C Stump United States 33 1.2k 1.3× 657 0.9× 1.0k 1.6× 287 0.7× 784 2.0× 67 3.1k
Mark Blostein Canada 28 607 0.7× 603 0.9× 445 0.7× 301 0.7× 413 1.1× 81 2.2k
Sarfraz Ahmad United States 34 204 0.2× 359 0.5× 369 0.6× 800 1.9× 1.2k 3.1× 223 4.0k
Juan Carlos Souto Spain 31 1.0k 1.1× 1.3k 1.9× 1.9k 2.9× 395 0.9× 487 1.2× 145 3.7k
Maureen G. Conlan United States 30 367 0.4× 248 0.4× 948 1.4× 287 0.7× 256 0.7× 73 2.7k
Andrew Mumford United Kingdom 38 949 1.0× 581 0.8× 3.0k 4.5× 674 1.6× 560 1.4× 137 5.0k
Joyce Curvers Netherlands 24 277 0.3× 453 0.6× 1.1k 1.6× 203 0.5× 130 0.3× 41 1.9k

Countries citing papers authored by C Chatelain

Since Specialization
Citations

This map shows the geographic impact of C Chatelain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Chatelain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Chatelain more than expected).

Fields of papers citing papers by C Chatelain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Chatelain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Chatelain. The network helps show where C Chatelain may publish in the future.

Co-authorship network of co-authors of C Chatelain

This figure shows the co-authorship network connecting the top 25 collaborators of C Chatelain. A scholar is included among the top collaborators of C Chatelain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Chatelain. C Chatelain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ligneul, Clémence, C Chatelain, Christophe Barrea, et al.. (2025). Autistic behavior is a common outcome of biallelic disruption of PDZD8 in humans and mice. Molecular Autism. 16(1). 14–14.
2.
Bouvy, Céline, et al.. (2018). Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma:\nA Pilot Prospective Longitudinal Clinical Study. Europe PMC (PubMed Central). 14 indexed citations
3.
Devos, Timothy, Stef Meers, Nancy Boeckx, et al.. (2018). Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel. European Journal Of Haematology. 101(6). 737–749. 31 indexed citations
4.
Haguet, Hélène, Jonathan Douxfils, C Chatelain, et al.. (2017). Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture. Blood. 130. 1591–1591. 1 indexed citations
5.
Devos, Timothy, Pierre Zachée, Dominique Bron, et al.. (2014). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica. 70(2). 105–111. 6 indexed citations
6.
Gheldof, Damien, François Mullier, Bernard Châtelain, Jean‐Michel Dogné, & C Chatelain. (2013). Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles. Blood Coagulation & Fibrinolysis. 24(5). 567–572. 14 indexed citations
7.
Babili, Fatiha El, et al.. (2012). Velamo do Campo : Its Volatile Constituents, Secretory Elements, and Biological Activity. Journal of Medicinal Food. 15(7). 671–676. 4 indexed citations
8.
Mullier, François, Nicolas Bailly, C Chatelain, Bernard Châtelain, & Jean‐Michel Dogné. (2012). Quantification and characterization of microvesicles: Applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 3. 157–160. 3 indexed citations
9.
Osselaer, Jean‐Claude, Chantal Doyen, C Chatelain, et al.. (2006). Impact of photochemical treatment (intercept) on platelet use in routine practice. Digital Access to Libraries. 91. 180–180. 1 indexed citations
10.
Baatout, Sarah, et al.. (2000). The G and F contents in megakaryocyte cell lines after stimulation with phorbol myristate acetate.. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 19(4B). 3259–64. 1 indexed citations
11.
Chatelain, C. (2000). [Joachin Albarran (1860-1912)].. PubMed. 125(1). 81–8. 3 indexed citations
12.
Chatelain, C. (2000). [Albarran and microbial nephritis].. PubMed. 21(4). 185–92. 3 indexed citations
13.
Lebrét, Thierry, et al.. (1995). Malformation du système veineux rénal et cave caudal révélée par des hématuries récidivantes. Progrès en Urologie. 5(6). 1 indexed citations
14.
Châtelain, Bernard, et al.. (1995). Induction and enhancement of normal human megakaryocyte polyploidization are concomitant with perturbation in actin metabolism.. Blood. 86(10). 1438–1438. 1 indexed citations
15.
Collignon, Joëlle, et al.. (1994). Rapid Diagnosis of Cerebral Toxoplasmosis By Pcr in Allogeneic Bmt Leads To Early and Successful Treatment. Blood. 84(10).
16.
Bosly, André, Augustin Ferrant, André Delannoy, et al.. (1993). 2-chlorodeoxyadenosine Therapy in Non-hodgkins-lymphoma. Blood. 82(10). 2 indexed citations
17.
Baatout, Sarah, et al.. (1993). Nucleolar Organizer Regions of Megakaryocyte Cell-lines Augment After Induction of Polyploidization By Cytochalasin-b. Experimental Hematology. 21(8). 1039–1039. 1 indexed citations
18.
Ravoet, Christophe, Martine Piccart, Dominique Bron, et al.. (1992). A phase I clinical trial of recombinant human interleukine-6 (rhIL-6) in solid tumors. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 232. 1 indexed citations
19.
Chatelain, C, et al.. (1985). Invivo Enhancement of Granulopoiesis - Proportionality To the Intensity of the Inflammatory Stimulus and Requirement of a Cyclosphorin-a Responsive Cell. Experimental Hematology. 13(5). 329–329. 1 indexed citations
20.
Chatelain, C, et al.. (1970). [Long-term results of ureterosigmoidostomies for bladder exstrophy].. PubMed. 76(12). 385–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026